retatrutide release Helped Adults With Diabetes or Heart Disease Lose Up to 20 Percent of Their Weight, Study Finds Retatrutide, an experimental weight-loss drug,

Safety in specific populations Older adults: Generally safe, may need dose adjustment for reduced kidney function

Even though the application of FMT remains experimental, some studies show small benefits toward lowering depressive symptoms (Green et al., 2023)

Kreider RB, et al

Based on the matched data from the same individual including the abundance of bacterial genera and the plasma levels of identified BAs or metabolites, hierarchical clustering of Spearman correlations was performed with the software R 3.4.2 Heatmap package

References: None Loren Pickart, Vasquez-Soltero JM, Pickart FD, None John Majnarich